Brief: Agile Therapeutics- On Dec 5, Got Letter From Nasdaq, Co Granted Additional Period, Until Feb 16, 2024, To Regain Compliance For Continued Listing
06/12/2023 13:18
Dec 6 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS- ON DEC 5, GOT LETTER FROM NASDAQ, CO
GRANTED
ADDITIONAL PERIOD, UNTIL FEB 16, 2024, TO REGAIN COMPLIANCE FOR
CONTINUED LISTING
Source text for Eikon: ID:
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt